Opportunity Information: Apply for RFA CA 09 016
Apply for RFA CA 09 016
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Developing Research Capacity in Africa for Studies on HIV Associated Malignancies (D43)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398 Cancer Research Manpower 93.989 International Research and Research Training.
- This funding opportunity was created on Sep 22, 2009 and posted on Sep 22, 2009.
- Applicants must submit their applications by Dec 17, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Developing Research Capacity in Africa for Studies on HIV Associated Malignancies (D43)" (Funding Opportunity Number RFA-CA-09-016) is a National Institutes of Health initiative, led through the National Cancer Institute, focused on building sustainable cancer research training capacity in sub-Saharan Africa. The central aim is to strengthen the ability of African institutions and investigators to conduct high-quality research on cancers linked to HIV infection, an area of major public health importance in the region. Rather than funding a single research project, the program is designed to support structured training efforts that expand local expertise, strengthen institutions, and lay the groundwork for future competitive, hypothesis-driven research studies.
A key feature of this FOA is the requirement for strategic, collaborative training programs built on partnerships between U.S. and African researchers. Applicants are expected to propose programs that do more than offer isolated workshops or short courses; the intent is to create durable, multidisciplinary research teams based in Africa. These teams should bring together the range of roles needed to carry out modern cancer and HIV-related research, including physicians and other clinical investigators, basic science researchers, epidemiologists, pathologists, data managers, and other essential personnel. The expectation is that training will be integrated and practical, helping institutions develop the full pipeline required for designing studies, collecting and managing data, handling specimens, performing analyses, and publishing results.
The long-term vision, explicitly described as extending beyond the immediate scope of this funding period, is that these African-led teams will become strong and efficient scientific partners in international collaborations focused on HIV-associated malignancies in sub-Saharan Africa. In other words, the program is meant to shift capacity toward locally anchored expertise so that African investigators and institutions can participate as equal partners in future research endeavors with investigators from the U.S. and other developed countries. To align with that goal, proposals are expected to be strongly oriented toward enabling future hypothesis-driven studies that could later compete successfully for support from other funding sources. The training plan should therefore be designed with an eye toward producing investigators and teams capable of developing fundable research questions, writing competitive grant applications, and carrying out rigorous studies.
This opportunity uses the NIH D43 mechanism, which is an international research training grant mechanism typically aimed at building research capacity through education and hands-on training. The FOA is categorized as discretionary funding and listed under education and health funding activities. The CFDA numbers associated with the announcement include 93.398 (Cancer Research Manpower) and 93.989 (International Research and Research Training), reflecting its emphasis on developing the human and institutional resources needed for cancer research in international settings.
In terms of funding, NIH anticipated a total investment of about $4,000,000 per year to support roughly 6 to 7 awards under this initiative. The award ceiling listed is $500,000. Facilities and administrative (indirect) costs are capped at 8% for all awards and subawards, which is a notable constraint for budgeting and is typical of some international training and capacity-building programs. There is no cost-sharing or matching requirement, meaning applicants are not required to provide matching funds as a condition of eligibility.
Eligible applicants include a range of U.S.-based organizations that can support international training partnerships: public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (both with and without 501(c)(3) status, as specified). While the eligible applicant types are U.S. entities, the program itself is clearly oriented toward building research capacity at African institutions through collaborative training structures, implying that strong, well-defined partnerships with African counterparts are essential for a credible application.
The announcement was posted and created on September 22, 2009, with an original and current closing date of December 17, 2009, and an archive date of January 17, 2010, indicating that this is an archived funding opportunity from that period. The full announcement was made available through the NIH grants guide, and contact support for technical access issues was provided through the NIH Office of Extramural Research (OER) webmaster.
Frequently Asked Questions (FAQs)
What is the official title and number of this grant opportunity?
The opportunity is titled "Developing Research Capacity in Africa for Studies on HIV Associated Malignancies (D43)." The Funding Opportunity Number is RFA-CA-09-016.
Which federal agency and NIH institute are leading this funding opportunity?
This is a National Institutes of Health (NIH) initiative led through the National Cancer Institute (NCI).
What is the main purpose of this FOA?
The central purpose is to build sustainable cancer research training capacity in sub-Saharan Africa, specifically focused on cancers linked to HIV infection. The program is intended to strengthen African institutions and investigators so they can conduct high-quality research in this area.
Is this funding meant to support a single research project?
No. The program is designed to support structured research training efforts that expand local expertise, strengthen institutions, and lay the groundwork for future competitive, hypothesis-driven research studies, rather than funding one stand-alone research project.
What kinds of activities is the program trying to promote?
The FOA emphasizes practical, integrated training that helps build the full research pipeline needed for modern cancer and HIV-related studies. This includes developing capabilities for study design, data collection and data management, specimen handling, analysis, and publication.
What is a defining feature of the training programs expected under this FOA?
A key feature is strategic, collaborative training programs built on partnerships between U.S. and African researchers. The intent is to create durable, multidisciplinary research teams based in Africa, rather than isolated workshops or short courses.
What types of team roles does the FOA expect programs to bring together?
The FOA calls for multidisciplinary teams that include physicians and other clinical investigators, basic science researchers, epidemiologists, pathologists, data managers, and other essential personnel required to carry out cancer and HIV-related research.
What geographic region is the program focused on?
The program is focused on sub-Saharan Africa, with an emphasis on building research training capacity at African institutions.
What is the long-term vision of this initiative beyond the funding period?
The long-term vision is that African-led teams become strong and efficient scientific partners in international collaborations on HIV-associated malignancies in sub-Saharan Africa, with locally anchored expertise that supports equal partnership in future research endeavors.
How should applicants align their training plan with future research goals?
Proposals are expected to be oriented toward enabling future hypothesis-driven studies that could later compete successfully for support from other funding sources. Training should prepare investigators and teams to develop fundable questions, write competitive grant applications, and conduct rigorous studies.
What funding mechanism does this opportunity use?
This opportunity uses the NIH D43 mechanism, an international research training grant mechanism generally used to build research capacity through education and hands-on training.
How is this FOA categorized in terms of funding type and activity area?
It is categorized as discretionary funding and is listed under education and health funding activities.
What CFDA numbers are associated with this announcement?
The CFDA numbers listed are 93.398 (Cancer Research Manpower) and 93.989 (International Research and Research Training).
How much funding did NIH expect to invest each year, and how many awards were anticipated?
NIH anticipated a total investment of about $4,000,000 per year, supporting roughly 6 to 7 awards.
What is the award ceiling for this opportunity?
The listed award ceiling is $500,000.
Are indirect costs limited under this FOA?
Yes. Facilities and administrative (indirect) costs are capped at 8% for all awards and subawards, which is a significant budgeting constraint noted in the announcement.
Is cost sharing or matching required?
No. There is no cost-sharing or matching requirement, meaning applicants are not required to provide matching funds as a condition of eligibility.
Who is eligible to apply as the primary applicant organization?
Eligible applicants include U.S.-based organizations such as public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (with or without 501(c)(3) status, as specified).
If eligible applicants are U.S. organizations, how does the FOA address African institutions?
While eligible applicant types are U.S. entities, the FOA is explicitly oriented toward building research capacity at African institutions through collaborative training structures, implying that strong, well-defined partnerships with African counterparts are essential for a credible application.
When was this opportunity posted, and what were the key dates?
The announcement was posted and created on September 22, 2009. The original and current closing date listed is December 17, 2009. The archive date is January 17, 2010.
Is this funding opportunity currently active?
Based on the provided dates and the archive date of January 17, 2010, this is an archived funding opportunity from that period.
Where was the full announcement made available?
The full announcement was made available through the NIH grants guide.
Who was listed as the contact for technical access issues?
Technical access support was provided through the NIH Office of Extramural Research (OER) webmaster.
Browse more opportunities from the same category: Education Health
Next opportunity: NIH Blueprint for Neuroscience Research Competitive Revisions for Studies Focused on Neuropathic Pain or Neural Plasticity to Promote Collaborative Pain Research (R01)
Previous opportunity: Green and Healthy Homes and Technical Studies Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 09 016
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 09 016) also looked into and applied for these:
| Funding Opportunity |
|---|
| Medications Development for Cannabis Related Disorders (R01) Apply for RFA DA 10 016 Funding Number: RFA DA 10 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2010, 2011 and 2012 (P50) Apply for PAR 10 003 Funding Number: PAR 10 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Discovery for Nervous System Disorders (R21) Apply for PAR 10 002 Funding Number: PAR 10 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Drug Discovery for Nervous System Disorders (R01) Apply for PAR 10 001 Funding Number: PAR 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Community Networks Program (CNP) Centers for Reducing Cancer Disparities through Outreach, Research and Training (U54) Apply for RFA CA 09 032 Funding Number: RFA CA 09 032 Agency: National Institutes of Health Category: Education Health Funding Amount: $900,000 |
| Pathway to Independence Award in Cancer Nanotechnology Research (K99/R00) Apply for RFA CA 09 015 Funding Number: RFA CA 09 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Nanotechnology Training Centers (CNTCs)(R25) Apply for RFA CA 09 014 Funding Number: RFA CA 09 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $400,000 |
| Behavioral and Integrative Treatment Development Program (R01) Apply for PA 10 012 Funding Number: PA 10 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Behavioral and Integrative Treatment Development Program (R03) Apply for PA 10 011 Funding Number: PA 10 011 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Behavioral and Integrative Treatment Development Program (R34) Apply for PA 10 013 Funding Number: PA 10 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33) Apply for RFA CA 10 002 Funding Number: RFA CA 10 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Application and Early Stage Development of Emerging Technologies in Cancer Research (R21) Apply for RFA CA 10 003 Funding Number: RFA CA 10 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Innovative Technology Development for Cancer Research (R21) Apply for RFA CA 10 005 Funding Number: RFA CA 10 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) Apply for RFA CA 10 004 Funding Number: RFA CA 10 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Innovative and Early Stage Development of Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 10 001 Funding Number: RFA CA 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01) Apply for PAR 10 018 Funding Number: PAR 10 018 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Drug Abuse Dissertation Research Epidemiology, Prevention, Treatment, Services, and/or Women and Sex/Gender Differences (R36) Apply for PAR 10 020 Funding Number: PAR 10 020 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| AIDS Science Track Award for Research Transition (R03) Apply for PAR 10 021 Funding Number: PAR 10 021 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| State and Community Tobacco Control Policy and Media Research (U01) Apply for RFA CA 10 008 Funding Number: RFA CA 10 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Effectiveness Research on Smoking Cessation in Hospitalized Patients (U01) Apply for RFA HL 10 020 Funding Number: RFA HL 10 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 09 016", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
